2020 ASCO Virtual Direct™ Highlights

 

Avatar

2020 ASCO Update on Recurrent Ovarian Cancer: Does Secondary Cytoreductive Surgery Impact Patients Favorably?

By Total Health 1244 Videos FEATURING Carolyn Muller
24 views
October 13, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy
GYN
19:19

2020 ASCO Update on Recurrent Ovarian Cancer: Does Secondary Cytored…

Total Health

C. Muller

24 views
07:40

2020 ASCO Update on Platinum Sensitive, Relapsed Ovarian Cancer: Is …

Total Health

C. Muller

348 views
09:08

PARPi Efficacy in Recurrent Platinum Sensitive Ovarian Cancer: Is Ol…

Total Health

C. Muller

128 views